FEDRATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where FEDRATINIB was used for Neoplasm malignant.
Most Reported Side Effects for FEDRATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 143 | 10.2% | 13 | 28 |
| Death | 138 | 9.8% | 138 | 3 |
| Nausea | 114 | 8.1% | 0 | 13 |
| Fatigue | 105 | 7.5% | 0 | 10 |
| Vomiting | 74 | 5.3% | 10 | 20 |
| Constipation | 59 | 4.2% | 9 | 18 |
| Platelet count decreased | 48 | 3.4% | 0 | 10 |
| Asthenia | 47 | 3.4% | 2 | 14 |
| Haemoglobin decreased | 46 | 3.3% | 1 | 12 |
| Full blood count decreased | 45 | 3.2% | 0 | 14 |
| Drug ineffective | 42 | 3.0% | 0 | 1 |
| Anaemia | 41 | 2.9% | 1 | 11 |
| Off label use | 40 | 2.9% | 7 | 6 |
| Dizziness | 37 | 2.6% | 0 | 8 |
| Illness | 34 | 2.4% | 1 | 6 |
Other Indications for FEDRATINIB
Myelofibrosis (682)
Product used for unknown indication (307)
Myeloproliferative neoplasm (146)
Primary myelofibrosis (77)
Polycythaemia vera (69)
Off label use (56)
Essential thrombocythaemia (28)
Myelodysplastic syndrome (27)
Splenomegaly (11)
Hairy cell leukaemia (9)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)